Catalyst Pharmaceuticals Inc (CPRX) — Cash Flow-to-Debt Ratio
Catalyst Pharmaceuticals Inc (CPRX) has a Cash Flow-to-Debt Ratio of 0.44x as of March 2026, meaning its operating cash flow of $59.59 Million could theoretically repay 0% of its total liabilities ($134.91 Million) in one year. See financial agility of Catalyst Pharmaceuticals Inc to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Catalyst Pharmaceuticals Inc Cash Flow-to-Debt Ratio (2004–2025)
Historical debt coverage capacity for Catalyst Pharmaceuticals Inc across 22 annual periods. For the full cash flow conversion analysis, see Catalyst Pharmaceuticals Inc (CPRX) cash flow conversion.
Annual Cash Flow-to-Debt Ratio for Catalyst Pharmaceuticals Inc (2004–2025)
Year-by-year debt coverage analysis for Catalyst Pharmaceuticals Inc. Check earnings quality score of Catalyst Pharmaceuticals Inc to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 1.37x | $208.67 Million | $152.54 Million | ▼ -29.4% |
| 2024 | 1.94x | $239.81 Million | $123.78 Million | ▲ +10.9% |
| 2023 | 1.75x | $143.60 Million | $82.23 Million | ▲ +13.2% |
| 2022 | 1.54x | $116.05 Million | $75.21 Million | ▼ -20.9% |
| 2021 | 1.95x | $60.37 Million | $30.96 Million | ▼ -1.5% |
| 2020 | 1.98x | $45.03 Million | $22.76 Million | ▲ +41.5% |
| 2019 | 1.40x | $34.61 Million | $24.75 Million | ▲ +152.6% |
| 2018 | -2.66x | $-25.70 Million | $9.67 Million | ▲ +14.4% |
| 2017 | -3.11x | $-13.74 Million | $4.42 Million | ▲ +58.5% |
| 2016 | -7.49x | $-17.96 Million | $2.40 Million | ▼ -92.3% |
| 2015 | -3.89x | $-18.02 Million | $4.63 Million | ▼ -160.8% |
| 2014 | -1.49x | $-12.94 Million | $8.67 Million | ▲ +39.8% |
| 2013 | -2.48x | $-9.88 Million | $3.98 Million | ▼ -4.7% |
| 2012 | -2.37x | $-5.14 Million | $2.17 Million | ▼ -18.4% |
| 2011 | -2.00x | $-4.99 Million | $2.49 Million | ▲ +83.3% |
| 2010 | -11.98x | $-3.76 Million | $313.71K | ▲ +45.7% |
| 2009 | -22.05x | $-7.68 Million | $348.52K | ▼ -293.0% |
| 2008 | -5.61x | $-8.26 Million | $1.47 Million | ▲ +54.7% |
| 2007 | -12.39x | $-4.42 Million | $357.17K | ▼ -712.4% |
| 2006 | -1.52x | $-1.18 Million | $772.85K | ▼ -14.9% |
| 2005 | -1.33x | $-455.36K | $342.99K | ▲ +61.0% |
| 2004 | -3.40x | $-230.52K | $67.80K | — |